REVA Medical, Inc. Uncategorized Contracts & Agreements
43 Contracts & Agreements
- Order of the Bankruptcy Court, dated February 19, 2020, confirming the Prepackaged Chapter 11 Plan of REVA Medical, Inc (Filed With SEC on March 5, 2020)
- Restructuring Support Agreement, dated December 23, 2019 by and between the debtors and the Supporting Lenders (Filed With SEC on January 15, 2020)
- CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETED ASTERISKS [***], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION... (Filed With SEC on November 9, 2016)
- 5751 Copley Drive, Suite B, San Diego, CA 92111 (858) 966-3000 (858) 966-3099 (FAX) www.teamreva.com (Filed With SEC on March 17, 2014)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on November 12, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on November 12, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on November 12, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on November 12, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on November 12, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on November 12, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on November 12, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on November 12, 2010)
- Broker Code Adviser Code (Filed With SEC on November 12, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on October 22, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on October 22, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on October 22, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on October 22, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on October 22, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on October 22, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on October 22, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on October 22, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on October 22, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on September 21, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on September 21, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
- Adverse long-term reactions, including the potential for restenosis (Filed With SEC on August 13, 2010)
